Carregant...
Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
BACKGROUND: Diabetes mellitus type 2 (DM2) is a modifiable risk factor associated with pancreatic carcinogenesis and tumor progression on the basis of epidemiology studies, but the biological mechanisms are not completely understood. The purpose of this study is to demonstrate direct evidence for th...
Guardat en:
| Publicat a: | Gastroenterol Rep (Oxf) |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7434590/ https://ncbi.nlm.nih.gov/pubmed/32843973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goaa018 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|